AMG National Trust Bank Has $1.25 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

AMG National Trust Bank increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,391 shares of the medical equipment provider’s stock after buying an additional 154 shares during the period. AMG National Trust Bank’s holdings in Intuitive Surgical were worth $1,248,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. Berkshire Asset Management LLC PA acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $253,000. Marco Investment Management LLC lifted its position in shares of Intuitive Surgical by 271.7% in the 4th quarter. Marco Investment Management LLC now owns 1,996 shares of the medical equipment provider’s stock worth $1,042,000 after purchasing an additional 1,459 shares during the period. Ashton Thomas Private Wealth LLC lifted its position in shares of Intuitive Surgical by 153.5% in the 4th quarter. Ashton Thomas Private Wealth LLC now owns 2,241 shares of the medical equipment provider’s stock worth $1,170,000 after purchasing an additional 1,357 shares during the period. Draper Asset Management LLC boosted its stake in shares of Intuitive Surgical by 4.9% in the 4th quarter. Draper Asset Management LLC now owns 1,641 shares of the medical equipment provider’s stock valued at $884,000 after purchasing an additional 76 shares during the last quarter. Finally, Callan Family Office LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at $7,543,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CFO Jamie Samath sold 270 shares of the stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,579 shares of company stock worth $7,756,844 over the last quarter. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 3.8 %

Intuitive Surgical stock opened at $518.26 on Friday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The firm has a market capitalization of $184.59 billion, a price-to-earnings ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The firm’s fifty day moving average price is $571.36 and its two-hundred day moving average price is $531.20.

Analysts Set New Price Targets

ISRG has been the topic of a number of analyst reports. Leerink Partners upped their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Raymond James upped their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. UBS Group upped their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Finally, Citigroup upped their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.